Tuesday, May 28, 2024 episode artwork

EPISODE · May 28, 2024 · 7 MIN

Tuesday, May 28, 2024

from The Gist Healthcare Podcast

Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled dangerous substances. That’s coming up on today’s episode of Gist Healthcare Daily.  Hosted on Acast. See acast.com/privacy for more information.

NOW PLAYING

Tuesday, May 28, 2024

0:00 7:23

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Gist Healthcare Podcast?

This episode is 7 minutes long.

When was this The Gist Healthcare Podcast episode published?

This episode was published on May 28, 2024.

What is this episode about?

Novo Nordisk reports that its GLP-1 drug Ozempic could help treat kidney disease. An advisory panel recommends the FDA approve Guardant Health’s colon cancer blood test. And Louisiana lawmakers vote to reclassify abortion pills as controlled...

Can I download this The Gist Healthcare Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!